NasdaqGS - Delayed Quote USD

Sotera Health Company (SHC)

11.40 +0.08 (+0.71%)
At close: April 26 at 4:00 PM EDT
11.40 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,049,288.00
1,049,288.00
1,003,687.00
931,478.00
818,158.00
Cost of Revenue
472,130.00
472,130.00
446,683.00
412,806.00
374,586.00
Gross Profit
577,158.00
577,158.00
557,004.00
518,672.00
443,572.00
Operating Expense
300,466.00
300,466.00
308,654.00
261,939.00
237,554.00
Operating Income
276,692.00
276,692.00
248,350.00
256,733.00
206,018.00
Net Non Operating Interest Income Expense
-142,878.00
-142,878.00
-80,144.00
-74,192.00
-215,259.00
Other Income Expense
-27,787.00
-27,787.00
-411,317.00
-6,825.00
-29,619.00
Pretax Income
106,027.00
106,027.00
-243,111.00
175,716.00
-38,860.00
Tax Provision
54,651.00
54,651.00
-9,541.00
58,595.00
-1,369.00
Net Income Common Stockholders
51,376.00
51,376.00
-233,570.00
116,882.00
-38,617.00
Diluted NI Available to Com Stockholders
51,376.00
51,376.00
-233,570.00
116,882.00
-38,617.00
Basic EPS
-1.10
0.18
-0.83
0.41
-0.16
Diluted EPS
-1.10
0.18
-0.83
0.41
-0.16
Basic Average Shares
280,778.50
281,008.00
280,096.00
279,228.00
237,696.00
Diluted Average Shares
282,418.75
283,222.00
280,096.00
279,382.00
237,696.00
Total Operating Income as Reported
276,692.00
276,692.00
248,350.00
256,733.00
206,018.00
Total Expenses
772,596.00
772,596.00
755,337.00
674,745.00
612,140.00
Net Income from Continuing & Discontinued Operation
51,376.00
51,376.00
-233,570.00
116,882.00
-38,617.00
Normalized Income
79,151.61
79,151.61
167,792.90
131,563.12
-960.06
Interest Expense
142,878.00
142,878.00
80,144.00
74,192.00
215,259.00
Net Interest Income
-142,878.00
-142,878.00
-80,144.00
-74,192.00
-215,259.00
EBIT
248,905.00
248,905.00
-162,967.00
249,908.00
176,399.00
EBITDA
406,830.00
406,830.00
-17,413.00
400,810.00
319,962.00
Reconciled Cost of Revenue
378,004.00
378,004.00
364,069.00
325,685.00
290,052.00
Reconciled Depreciation
157,925.00
157,925.00
145,554.00
150,902.00
143,563.00
Net Income from Continuing Operation Net Minority Interest
51,376.00
51,376.00
-233,570.00
116,882.00
-38,617.00
Total Unusual Items Excluding Goodwill
-35,159.00
-35,159.00
-417,758.00
-22,026.00
-39,032.00
Total Unusual Items
-35,159.00
-35,159.00
-417,758.00
-22,026.00
-39,032.00
Normalized EBITDA
441,989.00
441,989.00
400,345.00
422,836.00
358,994.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-7,383.39
-7,383.39
-16,395.10
-7,344.88
-1,375.06
12/31/2020 - 11/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

QGEN Qiagen N.V.
41.65
+1.39%
 
NEOG Neogen Corporation
12.14
+1.51%
 
THOXF BioPorto A/S
0.3100
0.00%
 
SEQL SeqLL Inc.
1.3000
0.00%
 
BIAFW bioAffinity Technologies, Inc.
0.4500
+12.50%
 
0RUG.IL bioMérieux S.A.
100.94
+1.70%
 
CDNA CareDx, Inc
7.56
0.00%
 
TELO.V Telo Genomics Corp.
0.1700
-5.56%
 
XGN Exagen Inc.
1.4121
+0.86%
 
PMD Psychemedics Corporation
2.5500
-2.67%